Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C

Background: Peginterferon α-2b plus ribavirin therapy in previously untreated patients with chronic hepatitis C yields the highest sustained virological response rates of any treatment strategy but is expensive. Aims: To estimate the cost effectiveness of treatment with peginterferon α-2b plus ribav...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Siebert, U, Sroczynski, G, Rossol, S, Wasem, J, Ravens-Sieberer, U, Kurth, B M, Manns, M P, McHutchison, J G, Wong, J B
Formato: Artigo
Idioma:Inglês
Publicado em: Copyright 2003 by Gut 2003
Assuntos:
Hepatitis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773554/
https://ncbi.nlm.nih.gov/pubmed/12584228
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados